M/s. Servo-Med Industries Pvt. Ltd. v. Commissioner of Central Excise, Mumbai
Background
Between 1995 and 1997, the appellant purchased syringes and needles (on which excise duty had already been paid by their original manufacturers), sterilized them, and packed one syringe and one needle together in a branded plastic pouch for an industrial customer. The Excise Department issued a show cause notice claiming that sterilization created a new, different commodity, disposable syringes and needles, and demanded fresh excise duty on this basis. While the first appellate authority (Commissioner of Central Excise, Appeals) ruled in the assessee's favour, the CESTAT reversed this and held that a new commercially distinct product had emerged, making the activity dutiable as "manufacture."
Decision Breakdown
The Supreme Court examined precedents distinguishing cases where a genuinely new, distinct commercial product emerges (such as laminated kraft paper or bed sheets cut from cotton fabric) from cases where the basic article's identity and use remain unchanged. It held that sterilization and packaging did not transform the syringes and needles into a commercially new or different product: they were syringes and needles before sterilization and remained syringes and needles after, merely rendered usable/safe through the sterilization process, which did not amount to "manufacture" under excise law. The Court found that the CESTAT's reasoning had not correctly applied the settled legal test for what counts as "manufacture," set aside the CESTAT's judgment, and allowed the appellant's appeal.
Lesson Learnt
Merely processing, cleaning, sterilizing, or re-packaging a product that has already paid excise duty does not by itself amount to "manufacturing" a new, separately taxable product: fresh excise duty is only owed when the process actually creates a commercially distinct article with a different identity and use.